Oxford Asset Management LLP Makes New $978,000 Investment in Maximus, Inc. (NYSE:MMS)

Oxford Asset Management LLP purchased a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 13,097 shares of the health services provider's stock, valued at approximately $978,000.

A number of other institutional investors have also recently made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in shares of Maximus by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after acquiring an additional 205,564 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Maximus by 14.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock valued at $105,001,000 after acquiring an additional 177,075 shares during the last quarter. Van Berkom & Associates Inc. lifted its holdings in shares of Maximus by 8.5% in the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock valued at $93,792,000 after acquiring an additional 98,264 shares during the last quarter. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Maximus by 7.4% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider's stock valued at $92,188,000 after acquiring an additional 84,835 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Maximus by 7.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock valued at $74,700,000 after acquiring an additional 71,598 shares during the last quarter. Institutional investors own 97.21% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on MMS. StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd.

Maximus Trading Down 0.2 %

NYSE MMS traded down $0.12 during trading on Tuesday, hitting $67.41. The stock had a trading volume of 370,461 shares, compared to its average volume of 554,531. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The stock has a market capitalization of $3.82 billion, a price-to-earnings ratio of 14.50 and a beta of 0.68. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.97. The stock has a 50 day simple moving average of $67.64 and a 200 day simple moving average of $74.19.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Sell-side analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.78%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Insider Transactions at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.